|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 2000 GALLOPING HILL ROAD |
Address2 |
|
City | KENILWORTH |
State | NJ |
Zip Code | 07003 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 24908-12
|
||||||||
|
6. House ID# 313040000
|
TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Corey Malmgren |
Date | 1/21/2021 9:09:33 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 3, Lower Drug Costs Now Act of 2019, including provisions relating to international reference pricing
H.R. 19, Lower Costs, More Cures Act of 2019
H.R. 133, Consolidated Appropriations Act of 2021, including provision relating to vaccine funding and vaccinations
H.R. 4100/S. 1712, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019. including provisions relating to Anti-microbial Resistance
H.R. 4455, Bolstering Innovative Options to Save Immediately on Medicines (BIOSIM) Act
H.R. 4597, Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019
H.R. 4629, Star Rating for Biosimilars Act
H.R. 6197, Increasing Access to Biosimilars Act of 2020
H.R. 8061, Community Immunity During COVID-19 Act of 2020
H.R. 8920, The Pioneering Antimicrobial Subscriptions To End Up surging Resistance (PASTEUR) Act of 2020
S. 1895, Lower Health Care Costs Act
S. 2543, Prescription Drug Pricing Reduction Act of 2019
S. 4760, The Pioneering Antimicrobial Subscriptions To End Up surging Resistance (PASTEUR) Act 2020
Issues relating to,
340B Reforms;
340B program integrity;
340B of the Public Health Services Act;
340B policy;
340 drug pricing program;
Drug pricing;
Anti-microbial Resistance;
Biosimilars;
Maternal Health;
Cost and value of medicines;
Vaccines;
Supply chain;
COVID-19 vaccines;
COVID-19 issues;
Vaccines catch up;
General pharmaceutical issues;
Average Manufacture Price (AMP) cap;
Executive Order 13937, Access to Affordable Life-Saving Medications;
Department of Agriculture Center for Veterinary Biologics (CVB) funding.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Bradley |
Rossin |
|
|
|
Liz |
Schwartz |
|
|
|
Erin |
Darling |
|
|
|
Corey |
Malmgren |
|
|
|
Bob |
Filippone |
|
|
|
Adam |
Huftalen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 107, To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs
S. 476, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2019
S. 2543, Prescription Drug Pricing Reduction Act of 2019, including provisions relating to AMP cap and Medicare Part D rebate
Issues relating to,
Medicaid;
Medicare;
Medicare Part B;
Medicare Part B and D drug pricing issues;
340B reforms;
340B program integrity;
340B of the Public Health Services Act;
340B drug pricing issues;
Medicare Part D;
Drug Pricing;
Center for Medicare and Medicaid demonstrations.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Bradley |
Rossin |
|
|
|
Bob |
Filippone |
|
|
|
Liz |
Schwartz |
|
|
|
Corey |
Malmgren |
|
|
|
Erin |
Darling |
|
|
|
Adam |
Huftalen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issues related to,
Tax Reform, Generally;
Tax Cuts and Jobs Act of 2017 (P.L. 115-97)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Bradley |
Rossin |
|
|
|
Adam |
Huftalen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |